BACE1 and Alzheimer disease: Celastrol and Tanespimycin, which target the heat shock protein response, are other potential drugs showing promising results in transgenic mouse models of AD by preventing NFκB activation, inhibiting BACE1 expression and reducing Aβ40, Aβ42 levels as well as C99 and sAPPβ production and NFTs [217,218].